Quark announces a revision to an siRNA Pfizer agreement on diabetic macular edema
Quark Pharmaceuticals, a Californian based RNAi specialised biotech company, has announced changes to a Pfizer collaborative research agreement following receipt of results from a randomized… Read More »Quark announces a revision to an siRNA Pfizer agreement on diabetic macular edema